Evolus to Participate in November Investor Conferences
- None.
- None.
Event: |
Stifel 2023 Healthcare Conference |
||
Date: |
Wednesday, November 15, 2023 |
||
Time: |
11:30 AM ET |
||
Event: |
6th Annual Evercore ISI HealthCONx Conference |
||
Date: |
Tuesday, November 28, 2023 |
||
Time: |
9:35 AM ET |
Audio webcasts of these events will be available on the investor relations section of Evolus’ website at www.evolus.com. Replays of the webcasts will be available for 90 days after the date of each presentation.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau® (prabotulinumtoxinA-xvfs), globally licensed under the brand name Nuceiva®. The product is manufactured in a state-of-the-art facility using Hi-Pure™ technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive
Jeuveau® and Nuceiva® are registered trademarks of Evolus, Inc.
Evolysse™ is a trademark of Evolus, Inc.
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231031666324/en/
Investor Contacts:
Ned Mitchell
Arbor Advisory Group
Email: ir@evolus.com
Media Contact:
Email: media@evolus.com
Source: Evolus
FAQ
When will Evolus present at the Stifel 2023 Healthcare Conference?
When will Evolus present at the 6th Annual Evercore ISI HealthCONx Conference?
Where can I find the audio webcasts of the events?